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a b s t r a c t
Objective scar assessment tools were designed to help identify problematic scars and direct
clinical management. Their use has been restricted by their measurement of a single scar
property and the bulky size of equipment. The Scarbase Duo1 was designed to assess both
trans-epidermal water loss (TEWL) and colour of a burn scar whilst being compact and easy
to use.
Twenty patients with a burn scar were recruited and measurements taken using the
Scarbase Duo1 by two observers. The Scarbase Duo1measures TEWL via an open-chamber
system and undertakes colorimetry via narrow-band spectrophotometry, producing values
for relative erythema and melanin pigmentation. Validity was assessed by comparing the
Scarbase Duo1 against the Dermalab1 and the Minolta Chromameter1 respectively for
TEWL and colorimetry measurements.
The intra-class correlation coefficient (ICC) was used to assess reliability with standard
error of measurement (SEM) used to assess reproducibility of measurements. The Pearson
correlation coefficient (r) was used to assess the convergent validity.
The Scarbase Duo1 TEWL mode had excellent reliability when used on scars for both
intra- (ICC = 0.95) and inter-rater (ICC = 0.96) measurements with moderate SEM values. The
erythema component of the colorimetry mode showed good reliability for use on scars for
both intra-(ICC = 0.81) and inter-rater (ICC = 0.83) measurements with low SEM values.
Pigmentation values showed excellent reliability on scar tissue for both intra- (ICC = 0.97)
and inter-rater (ICC = 0.97) with moderate SEM values.
The Scarbase Duo1 TEWL function had excellent correlation with the Dermalab1
(r = 0.93) whilst the colorimetry erythema value had moderate correlation with the Minolta
Chromameter (r = 0.72).
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designed for burn scars. However, for clinical use, standardised measurement conditions
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Survival after severe burns and trauma has dramatically
improved over the last decade but this has not always been
paralleled with a similar increase in quality of life. Patients
have to contend with the sequelea of scarring, which can lead
to an array of appearance-related, psychological and func-
tional problems. Scars represent a significant challenge to the
multidisciplinary care team and a large burden on the
resources of health care systems. Research into the area of
improving treatment options for scarring is relevant both on
an individual and a societal level [1].
Scar assessment tools are used for monitoring the quality
of scars against time, the effect of treatments and for
comparing scars. The ideal scar assessment tool needs to be
reliable (error of measurement), valid (measures what it is
meant to measure) and feasible (easy to administer with
minimal patient burden). Scar assessment can be achieved via
subjective or objective methods. Subjectively, scars can be
assessed by patients, clinicians/medical professionals and
third party observers. However, subjective scales can be
unreliable due to a great variability in interpretation [2].
Various assessment scales have been created but the most
commonly used are the Vancouver Scar Scale (VSS) and the
Patient Observer Scar Assessment Scale (POSAS) [3–5].
Objective scar assessment has an advantage over subjec-
tive assessment because the reliability of measurements
between observers tends to be greater [6]. Objective scar
assessment tools can provide a quantitative measurement of
physiological or physical scar parameters. Physiological
properties include trans-epidermal water loss (TEWL), hydra-
tion, perfusion and trans-cutaneous oxygen level. Physical
properties include colour, elasticity, topography and plani-
metry [6].
TEWL is an important physiological marker to measure the
efficiency of the human skin barrier to retain water [7]. The
hydration and water content of skin is important as it helps to
maintain normal skin turgor and texture and is strongly
related to TEWL. TEWL can be used as an indirect measure-
ment of the barrier function of skin because when skin is
damaged, as is the case during scarring, TEWL increases [8].
Open chamber devices are the most common method of
measuring TEWL. They detect the water vapour gradient near
the surface of the skin based on the principle of Fick’s law of
diffusion [9].
Scar colour is a key physical property because its
comparison to uninjured, surrounding skin is correlated with
relative patient satisfaction and reflects biological processes
within the scar [10]. Colour assessment forms a component of
subjective scar assessment scales because patients commonlyPlease cite this article in press as: Fell M, et al. The Scarbase Duo1: Intr
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.0are dissatisfied with a mismatch of scar colour compared to
their surrounding skin. Clinically, colour assessment is useful
as an indicator of the scar maturation and as an early,
quantifiable index of the likelihood of the scar becoming
hypertrophic [11,12]. The colour of a scar is a complex physical
property that is contributed to by three main components
(brown melanin pigment, red oxyhemoglobin and yellow bile).
Colorimetry tools commonly assess the colour of scars via tri-
stimulus reflectance colorimetry (the level of light reflected
from the scar surface) or narrow-band spectrophotometry (the
absorption of light in the scar) [6].
Objective scar assessment tools have predominantly tested
a single characteristic of the scar and their use has largely been
restricted to the research settings due to their bulky,
impractical size. Anthonissen et al. were the first authors to
report about the utility of a dual scar assessment device called
the Dermalab1 (Cortex Technology, Hadsund, Denmark); this
measures both elasticity and TEWL via a single central unit [7].
A new device called the Scarbase Duo1 (Courage + Khazaka,
Cologne, Germany), calculating TEWL and colorimetry, has
been designed to be small, easy to use and affordable.
The aim of this study was to assess intra- and inter-rater
reliability, validity and feasibility of the Scarbase Duo1 for use
in research and clinical application.
2. Methods
This study was designed in accordance with the Guidelines for
reporting reliability and agreement studies [13].
2.1. Patients and observers
Patients were recruited from the OSCARE Centre (Burns and
Scar Aftercare Centre) in Antwerp, Belgium over a three week
testing period. Patients were eligible when they were at least
16 years old with scars in the active phase of healing after
complete wound closure. Previous treatment for these scars
followed a clinical protocol and was recorded in each patient.
Patients who were unable to provide consent due to a language
barrier or psychiatric disorder were excluded. Scars had to be
situated on the upper or lower limbs with the exclusion of the
hands, feet, trunk or head and neck. These chosen sites have
been shown to have lower and more consistent rates of TEWL
[14]. Contralateral areas of healthy skin were used for
comparison and in cases where these too were scarred,
adjacent healthy skin was tested. The two observers collecting
the data were a clinician and physiotherapist. The study
protocol was approved by the ethics committee of the Hospital
Network Antwerp (ZNA), Belgium (Ethical committee
009OG031, study number EC4549).a-rater and inter-rater reliability and validity of a compact dual scar
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The Scarbase Duo1 (Courage + Khazaka, Cologne, Germany)
device consists of a main unit, two probes and a sensor for
room temperature and humidity. The probes, one for the
Tewameter1 (TEWL) and one for the Mexameter1 (colorime-
try), attach to the main unit via independent leads into
separate channel inputs (see Fig. 1).
2.2.1. TEWL mode
The Tewameter1 (see Fig. 2) open chamber probe consists of a
hollow tube (1 cm  2 cm) containing combined humidity and
temperature sensors, positioned at different heights above the
skin surface. The local relative humidity and temperature are
recorded at both sites and a corresponding vapour pressure is
calculated automatically. TEWL is expressed in grams per
square metre per hour (g/m2/h). At the start of each testing
day, the Tewameter1 was calibrated. In order to measure
TEWL correctly, the open chamber was held perpendicular to
the scar or skin surface and away from a direct light source.
The small size of the chamber minimised the local airflows
known to distort open chamber results [15]. Patients were
asked to turn their face away from the Tewameter1 when
testing so that the air currents of breathing did not interfere
with assessments. Measurements were stopped after 30 s
(time required for TEWL equilibrium to be reached [16]) and
the mean/standard deviation of the TEWL measurements
were recorded.Fig. 1 – The Scarbase DuoW when linked up to a laptop.
There are 4 components displayed: the central unit, the
temperature sensor, the Tewameter probe and the
Mexameter probe.
Please cite this article in press as: Fell M, et al. The Scarbase Duo1: Intra
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.02.2.2. Colorimetry mode
The Mexameter1 (see Fig. 3) utilises narrow-band spectro-
photometry to measure the vascularity and pigmentation
(called erythema and melanin respectively) of the skin based
on differences in absorption of red and green light. The
haemoglobin component of skin reflects red light and absorbs
green whilst the brown of the melanin component absorbs
light of all wavelengths. The distal end of the probe is equipped
with a spring mechanism which calculates the colour
characteristics when a defined pressure is reached on the
skin surface. A separate measurement was created for
erythema and melanin. Measurements range from 1 to 1000
for both the erythema and melanin index with higher readings
representing more erythematous and darker pigmentation
respectively. Three measurements were taken in succession
and mean values were calculated.
2.3. Instruments to test for validity
2.3.1. Dermalab1
TEWL was assessed by the Dermalab1 (Cortex Technology,
Hadsund, Denmark) which is an open chamber system,
similar in design to the Tewamater1. The TEWL component
of the Dermalab1 is regarded as a typical open chamber TEWL
device and has been used experimentally before as a baseline
for validity due to its accurate and concise measuring
mechanism [16,17]. The Dermalab1 has not previously been
validated for testing TEWL in scars [7].
2.3.2. The Chromameter1
The Minolta Chromameter1 (Minolta Camera Co., Osaka,
Japan) utilises tri-stimulus reflectance colorimetry according
to the Commission International de L’E´clairage system
producing a three dimensional measurement (L* represents
the relative brightness (with a scale of 0–100), a* represents the
range of green (60) to red (60) reflected light, and b* represents
the range of blue (60) to yellow (60) reflected light). Higher
values for a* correspond with increasing redness of the scar
[18]. The Chromamater1 has shown excellent intra- and inter-
rater reliability along with moderate correlation to the colour
and vascularity component of the POSAS scale [19]. ThreeFig. 2 – The TewameterW probe to measure trans-epidermal
water loss.
-rater and inter-rater reliability and validity of a compact dual scar
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and mean values for the L*, a* and b* were calculated.
2.4. Measurement procedure
Informed written consent was obtained from all patients.
Thirty minutes before measurements were taken, patients
acclimatised to the testing environment by waiting in the
testing room, in the position in which they were to be tested
and with the scars and corresponding healthy skin uncovered.
The patients were in a sitting position for scars on the upper
limb and a lying position for scars on the lower limb. Testing
was performed in the same room with room temperature and
humidity recorded immediately prior to the start of measure-
ments being taken. Care was taken to place the temperature
and humidity sensor away from any heat source (e.g. patient
or computer). The boundaries of the test sites were marked
with circular adhesive markers.
Two consecutive measurements were taken by the first
rater for TEWL and colorimetry using the Scarbase Duo1 on
the scar and healthy skin. The first rater then measured the
same areas with the Chromamater1 and the Dermalab1. The
second rater conducted a single measurement for TEWL and
colorimetry using the Scarbase Duo1 on the identical scar
and healthy skin sites. A period of four minutes was observed
between any TEWL measurement or any colorimetry mea-
surement. This allowed both equilibrium time for condensa-
tion in the TEWL probe (=zero-drift) and the skin capillary
refill time recovery after pressure from the colorimetry
device [7].
2.5. Statistical analysis
Statistical analysis was performed using the statistical
programme SPSS v20.0 (Armonk, NY: IBM Corp.).
2.5.1. Reliability
Reliability refers to the consistency of the assessment tool
measurements (i.e. whether measurement is the same when
no real change has occurred). The intra-class correlationPlease cite this article in press as: Fell M, et al. The Scarbase Duo1: Intr
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.0coefficient (ICC) with its 95% confidence interval was used to
measure the intra- and inter-rater reliability on scars and
normal skin [20]. A two-way random-effect model and
absolute agreement was selected and calculated for all of
the scores. The Fleiss and Shrout classification for reliability
coefficients (ICC2,1) was used to describe the degree of
reliability [20]. The single measure ICC was used to interpret
the results. Reliability was judged to be good if the ICC was
>0.75, moderate 0.4–0.75 or poor <0.4 [21]. The reproducibility
of the Scarbase measurements was deduced via the standard
error of measurement (SEM), calculated by dividing the
standard deviation of the difference between mean scores
at baseline and follow-up (SDd) by the square root of two
(SEM = SDd/H2). This quantifies the variability of the differ-
ence scores and is referred to as the typical error of
differences [22]. Bland–Altman plots and limits of agreement
were used to analyse the repeatability of a single measure-
ment method and to compare measurements between two
raters [23].
2.5.2. Validity
Validity refers to the truth of the assessment tool measure-
ments (i.e. whether the tool is measuring what it is meant to).
Tests of validity are indirect and rely on comparison against a
method believed to be correct. Pearson’s correlation coeffi-
cients were calculated to assess the convergent validity of
the Scarbase Duo1 compared to other assessment tools.
Validity was judged to be good if the Pearson’s correlation or
the ICC was >0.6, moderate 0.3–0.6 or poor <0.3 [21]. Where
necessary, data was transformed using linear regression
scales. Bland–Altman plots and limits of agreement were
used to analyse the agreement of the two measurement
methods [23].
3. Results
3.1. Patient and scar characteristics
Twenty burn scars were included from twenty Caucasian
patients, 16 of whom were male with a mean age of 45 years
(SD 18.22). Eleven of the scars were located on the arm (four
upper arm and seven forearm) and nine were located on the
leg (five upper and four lower leg) with an overall mean scar
age of 5.65 months (SD 5.76). Eight of the scars had healed
spontaneously with the remaining twelve having received a
split skin graft. Taking into account the definition of
hypertrophic scars [24] and the correlation between scar
redness and scar thickness [11], we identified that eighteen
out of the twenty scars had developed into hypertrophic
scars.
The values for Tewameter1TEWL in healthy skin and scars
ranged from 3.7 to 12.4 g/m2/h (mean 6.3, SD 2.5) and 4.9 to
26.0 g/m2/h (mean 9.9, SD 5.2) respectively. The values for the
Mexameter1 erythema in healthy skin and scars ranged from
115.7 to 343.3 (mean 215.0, SD 66.3) and 297 to 648 (mean 449.6,
SD 86.76) respectively. The values for the Mexameter1
pigmentation in healthy skin and scars ranged from 56.3 to
317.67 (mean 162.1, SD 76.6) and 6.7 to 374.0 (mean 161.7, SD
85.2) respectively.a-rater and inter-rater reliability and validity of a compact dual scar
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Table 1 – ICCs and SEMs for the intra- and inter-rater reliability of the trans-epidermal water loss measurements with the
TewameterW. Measurements were taken on scars and adjacent healthy skin. A 95% confidence interval is marked
between brackets.
Type Meana SDa ICC (95% CI) SEM
Intra-rater reliability Scar 9.83 5.32 0.95 (0.89–0.98) 1.17
Healthy skin 6.05 2.3 0.87 (0.66–0.95) 0.74
Inter-rater reliability Scar 9.97 5.53 0.96 (0.9–0.98) 1.12
Healthy skin 6.23 2.21 0.9 (0.78–0.96) 0.75
a Values expressed in g/m2/h.
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3.2.1. Tewameter1 TEWL values
The ICC values ranged from 0.87 to 0.95 for the intra-rater and
0.9 to 0.96 for inter-rater reproducibility. This showed good to
excellent correlation for repeated TEWL measurements and
was combined with moderate SEM values (see Table 1). The
Bland–Altman plots for the intra- and inter-rater agreement of
two measurements on scars show that the bias of the mean is
low, suggesting that no systematic error could be detected.
The limits of agreement are far apart, suggesting that the high
correlation between the repeated measures and the two raters
is not supported by a high agreement (see Fig. 4).Fig. 4 – Bland–Altman plots for the Tewameter intra (1.1–
1.2) and inter (1.1–2.1)-rater agreement on on scars (plates
a and b).
Please cite this article in press as: Fell M, et al. The Scarbase Duo1: Intra
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.03.2.2. Mexameter1 erythema values
The ICC values ranged from 0.81 to 0.94 for the intra-rater and
0.83 to 0.96 for the inter-rater reproducibility. This showed
good to excellent correlation for repeated erythema mea-
surements, which was combined with relatively low SEM
values (see Table 2). The Bland–Altman plots of the intra- and
inter-rater agreement of two measurements in scars show
the bias of mean to be low, suggesting that no systematic
error could be detected. The limits of agreement are far apart,
but this could be due to a few outliers. 85% of the mean
differences are within the acceptable limits of agreement
(see Fig. 5).Fig. 5 – Bland–Altman plots for the Mexameter erythema
intra (1.1–1.2) and inter (1.1–2.1)-rater agreement on scars
(plates a and b).
-rater and inter-rater reliability and validity of a compact dual scar
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Table 2 – ICCs and SEMs for the intra- and inter-rater reliability of the erythema measurements with the MexamaterW.
Measurements were taken on scars and adjacent healthy skin. A 95% confidence interval is marked between brackets.
Type Meana SDa ICC (95% CI) SEM
Intra-rater reliability Scar 453 8.92 0.81 (0.58–0.92) 39.75
Healthy skin 210.54 68.03 0.94 (0.84–0.98) 15.74
Inter-rater reliability Scar 452.2 452.2 0.83 (0.63–0.93) 38.88
Healthy skin 215.24 67.5 0.96 (0.91–0.99) 13.36
a Values expressed in arbitrary units.
Table 3 – ICCs and SEMs for the intra- and inter-rater reliability of the pigmentation measurements with the MexamaterW.
Measurements were taken on scars and adjacent healthy skin. A 95% confidence interval is marked between brackets.
Type Meana SDa ICC (95% CI) SEM
Intra-rater reliability Scar 115.69 85.44 0.97 (0.92–0.99) 15.52
Healthy skin 162.51 77.65 0.97 (0.93–0.99) 13.35
Inter-rater reliability Scar 114.27 80.42 0.97 (0.92–0.99) 14.58
Healthy skin 161.81 76.84 0.99 (0.97–0.99) 8.71
a Values expressed in arbitrary units.
Fig. 6 – Bland–Altman plots for the Mexameter
pigmentation intra (1.1–1.2) and inter (1.1–2.1)-rater
agreement on scars (plates a and b).
b u r n s x x x ( 2 0 1 6 ) x x x – x x x6
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The ICC values ranged from 0.96 to 0.97 for intra-rater and 0.97
to 0.99 for intra-rater reproducibility. This showed excellent
correlation for repeated pigmentation measurements and was
combined with moderate SEM values on scarred skins and
relatively low SEM values on healthy skin (see Table 3). The
Bland–Altman plots for the intra- and inter-rater agreement of
two measurements on scars show the bias of the mean to be
low, suggesting that no systematic error could be detected.
The limits of agreement are far apart, suggesting that the high
correlation between the repeated measures and the two raters
is not supported by a high agreement (see Fig. 6).
3.3. Validity
3.3.1. Validating TEWL values from the Tewameter1 function
of the Scarbase Duo1 against the Dermalab1
The ICC value and the Pearson correlation coefficient (ICC 0.81,
r 0.93) show good to excellent correlation for scars between the
Tewameter1 and the Dermalab1. Moderate correlation (ICC
0.52, r 0.72) is shown between the two tools on healthy skin
(see Table 4). The Bland–Altman plots for agreement between
the two tools on scars show us that the bias of the mean is
high, suggesting that a systematic error could be detected. The
Dermalab1 TEWL probe systematically measures approxi-
mately 2.5 g/m2higher than the Tewameter1TEWL probe. The
limits of agreement are far apart, suggesting that the high
correlation between the two measurement methods is not
supported by high agreement (see Fig. 7).
3.3.2. Validating erythema values from the Mexameter1
function of the Scarbase Duo1 against the Chromameter1 a*
values
The ICC values and the Pearson correlation coefficient (ICC
0.47, r 0.72) show moderate to good correlation for scars
between the Mexameter1 erythema values and the Chroma-
meter1 a* values. Excellent correlation (ICC 0.93, r 0.93) is seen
between the two measurement methods on healthy skin (see
Table 5). The Bland–Altman plots for the intra- and inter-rater
agreement of two measurements on scars show us that the biasPlease cite this article in press as: Fell M, et al. The Scarbase Duo1: Intr
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.0of the mean is low, suggesting that no systematic error could
be detected. The limits of agreement are far apart, suggesting
that the high correlation between the two measurement
methods is not supported by a high agreement (see Fig. 8).a-rater and inter-rater reliability and validity of a compact dual scar
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Table 4 – Concurrent validity of TEWL measurements on scarred and healthy skin between the Tewamater of the Scarbase
DuoW and the DermalabW.
Type Mean Scarbase Duoa Mean Dermalaba ICC (95% CI) Pearson r
Scar 9.91 12.75 0.81 (0.23–0.94) 0.93
Healthy skin 6.34 8.74 0.52 (0.02–0.79) 0.72
a Values expressed in g/m2/h.
Table 5 – Concurrent validity of colorimetry measurements on scarred and healthy skin between the MexameterW
erythema values of the Scarbase DuoW and the Minolta ChromameterW a*-values.
Type Mean Scarbase Duoa Mean Chromametera (transformed) ICC (95% CI) Pearson r
Scar 449.45 215 0.47 (0.11 to 0.8) 0.72
Healthy skin 447.17 216.65 0.93 (0.83–0.97) 0.93
a Values expressed in arbitrary units.
b u r n s x x x ( 2 0 1 6 ) x x x – x x x 7
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The Scarbase Duo1 has been designed to assess two objective
qualities within the scar (TEWL via the Tewameter1 and
colorimetry via the Mexameter1), to be compact and easy to
use. The Scarbase Duo1was shown to be reliable with good to
excellent correlation for repeated measurements and between
two observers (ICC  0.81) with low to moderate SEM values.
These results correspond with an earlier study concerning the
inter-rater reliability of the Mexameter1 on scars, although
intra-rater reliability has not previously been investigated [24].
The Tewameter1 has been shown to be able to differentiate
normal skin from mildly disrupted skin surface but has never
before been tested on scars [25]. The results found in this
report for the Tewameter1 are slightly favourable to the
findings of Anthonissen and co-workers for the Dermalab1 [7].
Bland–Altman plots and the limits of agreement only show
high agreement for the Mexameter1 erythema values. This is
not surprising since objective assessment of scar colour and
trans-epidermal loss are dependent upon several endogenous,
exogenous and environmental factors [26]. The discrepancy
between the high correlation values and the moderateFig. 7 – Bland–Altman plots for the agreement of trans-
epidermal loss assessment between the Tewameter and
the Dermalab on scar.
Please cite this article in press as: Fell M, et al. The Scarbase Duo1: Intra
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.0agreement can be related to the heterogeneity of the study
population and could be investigated on a more homogenous
population in the future.
The ICC values and the Pearson correlation coefficient
showed good to excellent correlation for scars between the
Tewameter1 and the Dermalab1. Moderate correlation was
found for measurements taken on healthy skin. The Bland–
Altman plots for the intra- and inter-rater agreement of two
measurements on scars show that the bias of the mean is high,
suggesting that a systematic error could be detected. The
Dermalab1 TEWL probe systematically measured 2.5 g/m2/h
higher than the Scarbase Duo1 TEWL probe. A linear
regression analysis established a statistically significant
correlation between both measurement methods. The regres-
sion equation was:
Tewameter1 value ¼ 0:76Dermalab1 value
The difference between the two could be due to different
calibration methods. One should also take into account that
the absolute value of one TEWL measurement ranges between
5 and 20 mg. To convert this value into g/m2/h increases the
risk of systematic error. Therefore, we suggest to use arbitrary
units to report TEWL values in the future.Fig. 8 – Bland–Altman plots for the agreement between the
Mexameter erythema values and the Chromameter a*
values on scar.
-rater and inter-rater reliability and validity of a compact dual scar
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showed moderate to good correlation for scars between the
Mexameter1 erythema values and the Chromameter1 a*
values. In healthy skin the two tools had excellent correlation.
The Bland–Altman plots for the intra- and inter-rater
agreement of two measurements on scars show us that the
bias of the mean is low, suggesting that no systematic error
could be detected. The limits of agreement are far apart,
suggesting that the high correlation between the two
measurements is not supported by a high agreement. A linear
regression analysis established a statistically significant
correlation between both measurement methods. The regres-
sion equation was:
Mexameter1 erythema value ¼ 27:02Chromameter1 a value
The most influencing factors for this moderate correlation
between the two measurement methods are likely to be the
differences in maintaining even pressure to avoid blanching of
the scar and the difference in skin measuring area, which
permits the influence of differing scar texture. The two devices
also make use of different colour assessment methods as the
Mexameter1 is a narrow band spectrophotometry device
whereas the Chromameter1 utilises a tri-stimulus reflectance
colorimeter. This makes comparison between the two tools
even more difficult.
We comment on the feasibility of the Scarbase Duo
through our experience of using the tool during the testing
process. The Scarbase Duo1 consists of a small, light body
with two small probes and immediate data logging on to the
computer. A computer is always needed, which makes
bedside testing difficult, but adds to uniform data storage
and the software is easy to use. The Tewameter1 probe is an
open-chamber system, and in our experience we recom-
mend the use of an air shield to avoid turbulence at the
measurement site. The possibility of on-site calibration of
the Tewameter1 probe is advantageous. More details
regarding the accurate usage of an open-chamber TEWL
device can be found in previous literature [9]. Design
advantages of the Mexameter1 probe include the spring-
mounted central portion which maintains even pressure per
measurement [24], whereas the Chromameter1 can cause
blanching of the skin when too much pressure is applied.
The meaning of the Mexameter1 erythema value is more
comprehensible than the meaning of the Chromameter1 a*
value.
5. Conclusion
The Scarbase Duo1 is a reliable and valid objective scar
assessment tool which has been specifically designed for use
in burn scars. Scar erythema and trans-epidermal water loss
are two valuable predictors of burn scar maturation, and as
such the Scarbase Duo1 can help to evaluate the effects of
different treatment protocols and develop practice guidelines
for burn scar management. For the detection of individual
clinical differences, we believe that this device may be
suitable, but further investigation on a more homogenous
population seems appropriate and standardised measure-
ment conditions are recommended.Please cite this article in press as: Fell M, et al. The Scarbase Duo1: Intr
assessment tool. Burns (2016), http://dx.doi.org/10.1016/j.burns.2015.08.0Conflict of interest
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